TITLE

1 October News

PUB. DATE
October 2012
SOURCE
Clinical Infectious Diseases;Oct2012, Vol. 55 Issue 7, pi
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers science news briefs as of October 1, 2012. The U.S. Disease Control and Prevention has recommended for the management of hepatitis B virus (HBV) infected healthcare providers to reduce the risk for transmitting HBV to patients during surgical procedures. Research scientists have discovered that H5N1 is three steps away from mutating into lethal human pandemic form. Gilead Sciences Inc. drug Truvada has been approved to reduce the risk of human immunodeficiency virus.
ACCESSION #
79888866

 

Related Articles

  • Improvements in HBV control measures needed across assisted living facilities.  // Endocrine Today;Jun2012, Vol. 10 Issue 6, p42 

    The article reports on the need to improve hepatitis B virus (HBV) control measures across assisted living facilities in the U.S., as indicated in a data published by the U.S. Centers for Disease Control and Prevention (CDC) in a 2012 issue of the journal "Morbidity and Mortality Weekly Report."

  • CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article focuses on the new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the usage of drugs from Gilead Sciences Inc. It informs that these guidelines are being opposed by AIDS Healthcare Foundation (AHF) due to unavailability of...

  • CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF.  // Biomedical Market Newsletter;8/15/2012, Vol. 21, p1 

    The article offers information that AIDS Healthcare Foundation (AHF) commented on the new guidance from the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the use of AIDS treatment drug Truvada from Gilead Sciences Inc. as pre-exposure prophylaxis (PrEP) from gay and...

  • "Compassionate Use" for Public Health. Feemster, Kristen A.; Offit, Paul // Annals of Internal Medicine;3/18/2014, Vol. 160 Issue 6, p421 

    The author reflects on eight cases of Neisseria meningitidis serogroup B (MenB) on March 22, 2013 which have occurred among students and visitors at the Princeton University. Topics discussed include the initiative taken by the Centers for Disease Control and Prevention of the U.S. to immunize...

  • Prevention of Vertical Transmission of Hepatitis B. Kubo, Ai; Shlager, Lyle; Marks, Amy R.; Lakritz, Dena; Beaumont, Colette; Gabellini, Kim; Corley, Douglas A. // Annals of Internal Medicine;6/17/2014, Vol. 160 Issue 12, p828 

    Background: For mothers with chronic hepatitis B virus (HBV) infection, the Centers for Disease Control and Prevention recommends immunoprophylaxis to decrease perinatal transmission. However, its effectiveness and risk factors for failure have not been well-studied in community practice....

  • Drug Combo Prevents HIV Infection in Monkeys.  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article reports on a study by Walid Heneine and colleagues at the United States Centers for Disease Control on the effectiveness of Gilead Science's drugs in preventing HIV infections in rhesus monkeys. The drugs are the tenofovir Viread and the emtracitibine Emtriva. The drugs were injected...

  • Truvada prevents HIV infection--now what?  // Advocate;5/9/2006, Issue 962, p21 

    The article reports on the significance of Truvada, a drug used for the treatment of AIDS, to the gay community. The U.S. Centers for Disease Control and Prevention released a study in March 2006 which showed that the drug prevented HIV infection in monkeys. Truvada manufacturer Gilead Sciences...

  • INFLUENZA ADVICE. Moscona, Anne // Crain's New York Business;10/31/2005, Vol. 21 Issue 44, p27 

    This article reports that the vaccine FluMist has been approved by the U.S. Centers for Disease Control for the treatment of influenza. It has been approved for persons ages 5 to 49, unless pregnant. Unfortunately, people who have influenza are contagious before they have symptoms. People should...

  • The new 9-valent HPV vaccine. Investor's Business Daily // Investors Business Daily;5/14/2015, pA02 

    The article reports on the release of a new 9-valent Human papillomavirus (HPV) vaccine revealed by the Centers for Disease Control and Prevention and was approved by the U.S. Food and Drug Administration (FDA) on December 2014.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics